Bexmarilimab Uses, Dosage, Side Effects and more
Bexmarilimab is under investigation in clinical trial NCT03733990 (A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients).
| Trade Name | Bexmarilimab |
| Generic | Bexmarilimab |
| Bexmarilimab Other Names | Anti-clever-1 monoclonal antibody FP-1305, Bexmarilimab, Clevegen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
